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Abstract
Sexual minority (i.e., non-heterosexual) individuals experience poorer mental and physical
health, accounted for in part by the additional burden of sexual minority stress occurring from
being situated in a culture favoring heteronormativity. Informed by previous research, the
purpose of this study was to identify the relationship between sexual minority stress and
leukocyte gene expression related to inflammation, cancer, immune function, and
cardiovascular function. Sexual minority men living with HIV who were on anti-retroviral
medication, had viral load < 200 copies/mL, and had biologically confirmed, recent
methamphetamine use completed minority stress measures and submitted blood samples for
RNA sequencing on leukocytes. Differential gene expression and pathway analyses were
conducted comparing those with clinically elevated minority stress (n = 18) and those who did
not meet the clinical cutoff (n = 20), covarying reactive urine toxicology results for very recent
stimulant use. In total, 90 differentially expressed genes and 138 gene set pathways
evidencing 2-directional perturbation were observed at false discovery rate (FDR) < 0.10. Of
these, 41 of the differentially expressed genes and 35 of the 2-directionally perturbed
pathways were identified as functionally related to hypothesized mechanisms of inflammation,
cancer, immune function, and cardiovascular function. The neuroactive-ligand receptor
pathway (implicated in cancer development) was identified using signaling pathway impact
analysis. Our results suggest several potential biological pathways for future work investigating
the relationship between sexual minority stress and health.
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1. Introduction
Sexual minority (non-heterosexual) individuals experience higher rates of both mental
(Cochran et al., 2004, Cochran et al., 2000, Cochran et al., 2003, Hughes and Eliason, 2002,
King et al., 2008, McCabe et al., 2003, Stall et al., 2001) and physical health problems
(Cochran and Mays, 2007, Conron et al., 2010). Meyer’s model of minority stress related to
sexual minority status (hereafter termed “sexual minority stress”), which includes experiences
and expectations of discrimination, internalization of societal stigma, and concealment of
sexual orientation, has garnered significant empirical support in explaining the the health
disparities that are observed among sexual minority individuals (Institute of Medicine, 2011,
McCabe et al., 2010, Meyer, 2003). Studies also document relationships between sexual
minority status and incidence of negative health outcomes such as cardiovascular disease
(Conron et al., 2010, Fredriksen-Goldsen et al., 2013), obesity (Conron et al., 2010,

Fredriksen-Goldsen et al., 2013), and diabetes (Fredriksen-Goldsen et al., 2013), though
studies are generally limited due to delays in the inclusion of sexual orientation in many largescale health data collection efforts (Sell and Holliday, 2014), and findings often differ between
sexual minority subgroups. Compared to heterosexual men, sexual minority men evidence preclinical indicators of risk for negative health outcomes such as high levels of C-reactive protein,
diastolic blood pressure, faster heart rate (Hatzenbuehler et al., 2013), and hypertension
(Everett and Mollborn, 2013). Research is needed to begin to investigate the mechanisms that
underly these health disparities among sexual minority people.
Studies are beginning to document associations between sexual minority stress processes and
biological and physiological outcomes. For example, Frost et al. (2015) found that the
experience of a prejudice event related to sexual minority status predicts subsequent report of
a physical health problem, including problems such as hypertension, illness, or cancer. Other
studies have examined cortisol responsiveness within the context of sexual minority stress. For
example, lesbian, gay, and bisexual people raised in environments where minority sexual
orientations are more highly stigmatized show blunted cortisol responses to social stress
(Hatzenbuehler and McLaughlin, 2014). In addition, openness about one’s sexual orientation in
the workplace is related to higher overall cortisol levels on workdays among sexual minority
men (Huebner and Davis, 2005). Further, the glucocorticoid resistance that can occur in
response to chronic stress is related to both a failure to downregulate inflammation and a less
effective immune response to a viral challenge (Cohen et al., 2012). Inflammation, in turn is an
important predictor of other health conditions (e.g., high blood pressure; Chae et al., 2001) as
well as greater risk for mortality for HIV-positive individuals (Tien et al., 2010) and among the
general population (Kabagambe et al., 2011), while impaired immunity can increase
vulnerability to disease. Sexual minority stress may also impact physiology through behavioral
pathways, for example sexual minority stress is related to substance use (Hatzenbuehler et al.,
2008, McCabe et al., 2010), which also impacts immune and inflammatory response (Cabral,
2006, Carrico et al., 2008, Cole et al., 1998, Pandrea et al., 2010, Sacerdote et al., 2012) and
cardiovascular function (Darke et al., 2008, Lange and Hillis, 2001). In sum, while the exact
mechanisms need further exploration, existing research on minority stress and chronic stress
suggests that minority stress may be related to inflammation, as well as immune and
cardiovascular function, which in turn may be related to poorer health outcomes observed
among sexual minority people.
Most of the existing research demonstrating associations between sexual minority stress and
biological outcomes has been conducted with HIV-positive populations. In the era prior to
highly active anti-retroviral therapy, HIV-positive men who concealed their sexual minority
status experienced accelerated progression of HIV, including faster progression to AIDS, AIDS
mortality, and lower CD4+ T-cell counts (Cole et al., 1996b). Concealment of sexual minority
status was also linked to greater likelihood of subsequent cancer or infection (Cole et al.,
1996a). Similarly, discomfort with situations in which one’s minority sexual orientation could be
evident was associated with faster progression to AIDS, AIDS mortality, and lower CD4+ T-cell
counts for sexual minority men living with HIV, though less so if one concealed their sexual
orientation (Cole et al., 1997). Even after the widespread use of highly active antiretroviral
therapy, the experience of victimization due to sexual orientation was shown to be related to
greater HIV viral load, and internalized stigma was related to lower CD4+ T-cell counts (Norcini

Pala et al., 2015). In the modern era of HIV treatment, studies with those who are receiving
effective HIV treatment have the potential to elucidate the biological pathways whereby stress
may contribute to inflammation and residual immune dysregulation (Lederman et al., 2013). In
sum, the existing research among HIV positive persons supports the hypothesis that minority
stress may be related to immune function, while also suggesting that cancer development may
be related to minority stress. Inflammation, immune function, cancer, and cardiovascular
function are all areas that may be considered in relationship to minority stress, based on
previous work on minority stress and the health implications of chronic stress.
Emerging research indicates that our social surroundings, the stressors associated with those
environments, and our perceptions of those stressors can change the expression of our genes
(Slavich and Cole, 2013), thereby altering complex biological processes. For instance, we
know that early adverse childhood experiences can influence subsequent inflammation (Miller
and Cole, 2012) and that interpersonal stress (Miller et al., 2009) and social isolation (Cole et
al., 2007) are related to expression of genes that drive inflammatory processes. Stress
exposure is related to increased expression of pro-inflammatory genes and reduced
expression of interferon response genes that are important for coordinating the immune
response to novel pathogens (Cole et al., 2011, Slavich and Cole, 2013; i.e., genes that
regulate against viral infections). Gene expression may have superior sensitivity in measuring
biological stress responses over serum markers, as evidenced by sensitivity to stressors or
interventions for stress management when no significant effects were detected in plasma
inflammatory markers such as interleukin 6 (IL-6) and C-reactive protein (Creswell et al., 2012,
Miller et al., 2009, Murphy et al., 2012). Gene expression may allow us to index responses to
stress with greater precision because of the upstream role it plays within the cascade of
biological events within the organism. Assessment of gene expression is a promising approach
for tracking the impact of psychological stress on health as it is capable of measuring both
biological responses to adversity (Slavich and Cole, 2013), and the reversal of those
responses through interventions (Antoni et al., 2012, Black et al., 2013, Creswell et al., 2012).
The purpose of this exploratory study is to identify if sexual minority stress is related to
differential expression of genes. Consistent with previous research and the minority stress
model, genes implicated in inflammatory processes, immune function, cancer, and
cardiovascular risk were examined. This model was tested within sexual minority men living
with HIV who were receiving effective treatment for HIV, as the potentially deleterious effects
of minority stress may be most evident in this population. We hypothesized that the association
of minority stress with leukocyte gene expression would be independent of recent stimulant
use.

2. Methods
Sexual minority men living with HIV with recent biologically verified methamphetamine use
(verified through urine or hair toxicology testing) were recruited from substance abuse
treatment programs, HIV medical clinics, AIDS service organizations, the community, and
referrals from other participants. Data collected for this study were collected at the baseline
visit of a randomized controlled trial and were collected prior to randomization. Participants met
with study staff to provide informed consent, which included specific consent for blood

specimen banking and analysis of gene expression. Inclusion criteria were: 1) 18 years of age
or older; 2) identify as gay or bisexual or are sexually active with men (i.e., sexual minority); 3)
provide documentation of HIV-positive serostatus; and 4) provide a urine or hair (only collected
for those whose urine toxicology was negative) sample that is reactive for methamphetamine
at the screening visit, which occurred prior to the baseline visit described here. Participants
were selected for this substudy to undergo RNA sequencing if they were on anti-retroviral
treatment (ART), had viral load <200 copies per mL, and completed measures of sexual
minority stress.
At the baseline visit, enrolled participants completed a battery of psychosocial measures,
provided an additional urine sample for on-site toxicology testing to index recent (∼72 h)
stimulant use, and provided a peripheral venous blood sample collected in two 2.5 mL
PAXgene® vacutainers (Qiagen, Inc.) for gene expression analyses and in vacutainers
containing the preservative EDTA to measure HIV disease markers and for specimen banking.
This study was approved by the Institutional Review Boards for the University of California,
San Francisco, University of Miami, and Northwestern University. A certificate of confidentiality
was obtained from the National Institute on Drug Abuse.

2.1. Measures
2.1.1. Demographics, health and psychiatric status, and HIV markers.
Participants completed a demographic questionnaire assessing age, race, ethnicity, and
health-related factors such as current HIV medication regimen. The Addiction Severity Index
(ASI) was used to measure severity of drug and alcohol use (McLellan et al., 1992). The 20item Centers for Epidemologic Studies Depression Scale (CES-D) measured depression
(Radloff, 1977). Possible Post Traumatic Stress Disorder (PTSD) was assessed using the
PTSD Checklist-Civilian Version (PCL-C; Wilkins et al., 2011). The Abbott Real Time HIV-1
assay (Abbott Molecular, Inc.; Des Plaines, IL), with a lower limit of detection of 40 copies/mL
was used to assess HIV viral load. CD4 + T-cell count was assessed by Quest Diagnostics
using a clinical assay.

2.1.2. Sexual minority Stress.
Sexual minority stress was measured using the five-item sexual minority stress subscale of the
Cultural Assessment of Risk for Suicide (CARS) scale (Chu et al., 2013), which is validated for
use with sexual minority people. This subscale captures distress related to sexual minority
stress, and includes items that reference constructs of concealment, internalized stigma, and
rejection from others. For example one item on this scale referencing concealment is “The
decision to hide or reveal my sexual or gender orientation to others causes me significant
distress,” while an item referencing rejection and stigma is “I was rejected by a family member
or friend after telling him/her my sexual or gender orientation.” Each item of the CARS is rated
on a scale from 1 to 6, ranging from “strongly disagree” to “strongly agree.” Scores were
calculated as specified within the CARS manual by summing the five items, with one item
reverse coded (Chu et al., 2013b). The sexual minority stress subscale of the CARS was
validated in the context of the relationship between minority stress and suicidality (Chu et al.,

2013), and cutoff scores were created to determine the level of clinical concern based on
responses to the CARS items (Chu et al., 2013b). Cutoff scores were derived based on the
relationships between these cutoff scores and increased risk of suicidal ideation, suicide
attempts, and hopelessness (Chu et al., 2013b). Within this sample, internal consistency of this
scale was 0.71. Participants were divided into low and high sexual minority stress groups using
cutoff scores deemed to be of clinical concern according to the CARS manual: ≤13,
corresponding to “minimal stress” and ≥14, corresponding to “moderate” or “severe” stress
(Chu et al., 2013b).

2.1.3. On-site urine screening.
On-site toxicology screening using iCup (Redwood Biotech, Inc., Santa Rosa, CA) was
conducted on urine samples. This was used to identify individuals who had used
methamphetamine or cocaine in the previous ∼72 h.

2.1.4. Pro-inflammatory cytokines in plasma.

Plasma levels of tumor necrosis factor-alpha (TNF-α) and IL-6 were examined within this
study. IL-6 was selected due to its relationship with stress and mortality (Papanicolaou, 1998),
and because IL-6 is associated with mortality specifically among persons living with HIV (Kuller
et al., 2008). TNF-α was selected because both TNF-α and IL-6 monocyte expression can be
altered by stimulant (i.e., cocaine) use (Irwin et al., 2007). TNF-α and IL-6 levels were obtained
via undiluted plasma samples using the Human Quantikine Immunoassay (R&D Systems,
Minneapolis, MN). Results were log10 transformed prior to use in analysis.

2.2. RNA sample preparation, sequencing, and analysis
2.2.1. Sample preparation and sequencing.
Total RNA was isolated from samples in PAXgene tubes using the PAXgene blood miRNA kit
(Qiagen). Library preparation and sequencing was done by a Core Facility, the Vincent J.
Coates Genomics Sequencing Laboratory at the University of California, Berkeley. Ribosomal
RNA was reduced using Ribo-Zero (Illumina Inc., San Diego, CA). RNAs were then prepared
for Illumina sequencing on an Apollo 324™ with PrepX™ RNAseq Library Prep reagents
(WaferGen Biosystems, Fremont, CA) following the manufacturer’s protocol. Thirteen cycles of
PCR amplification were used for single 6 base pair index addition and library fragment
enrichment. Prepared libraries were then quantified on a Roche LightCycler 480II (Roche
Diagnostics Corp., Indianapolis, IN) using KAPA Illumina library quantitative PCR reagents
(Roche Diagnostics Corp., Indianapolis, IN). Sequencing was done on an Illumina HiSeq 4000
apparatus (Illumina Inc., San Diego, CA). RNA-sequencing as a methodology has been
validated against other methodologies in multiple studies (see Fang and Cui, 2011 for a
discussion or Marioni et al., 2008 for previous validation).
In total, 72 samples were sequenced across 8 lanes, including 10 technical replicates, for a
total of 62 unique samples from 62 different participants. Of these 62 participants, 39 had
completed measures of minority stress, with 38 of these eligible for inclusion in the analyses in

this study. Nine samples were multiplexed per lane for 100 cycles of paired end reads with a
1% PhiX v3 control library spike in (Illumina Inc., San Diego, CA). Post-sequencing basecall
files (bclfiles) were demultiplexed and converted into FASTQ file format using the bcl2fastq
v2.17 software (Illumina Inc., San Diego, CA). Specific data processing procedures are
outlined in Supplemental Materials (S1). One sample from each replicate pair was excluded
using a coin-flip. Data exploration was performed with multi-dimensional scaling (MDS) plots
for all samples, and was used to identify potential batch effects due to technical artifacts (e.g.,
RNA quality, processing laboratory, technician, sequencing lane).
RNA-sequencing measurement of gene expression has been found to be a reliable and
reproducible technology, with the measurement of relative expression levels in high agreement
with qPCR and microarrays (Su et al., 2014). To evaluate the reproducibility of our
measurements (Allison et al., 2006), the 10 technical replicates were generated from
independent library preparations and sequenced in different lanes (Fang and Cui, 2011). The
reliability of the sequencing data was evaluated through alignment performance and MDS plots
between replicate pairs. The reproducibility of replicate count estimates was evaluated by
Pearson correlation.

2.3. Statistical analyses
Chi-square analyses and t-tests were used to examine differences in demographic and clinical
characteristics between low and high sexual minority stress groups, including: age, time since
HIV diagnosis, CD4+ T-cell count, number of days in the past 30 that methamphetamine was
used, severity of drug use, severity of alcohol use, depression (both continuous and using
cutoff scores of ≥16 consistent with a widely used clinical cutoff for depression, Vilagut et al.,
2016), PTSD symptoms, sexual orientation, race, proportion on different ART regimens,
proportion with undetectable HIV viral load (<40 copies/mL), and toxicology that was positive
or negative for stimulants. Differences in these demographic and clinical characteristics were
also examined between participants who had RNA sequenced who had received minority
stress measures and those who had participated in the study before these measures were
integrated into the protocol. T-tests were used to examine differences in log10 transformed
plasma levels of TNF-α and IL-6 by low and high sexual minority stress. Levels of TNF-α and
IL-6 are reported here to identify if results of gene expression assays that pertain to
inflammation are also observed in plasma. Differential expression was examined using a
variance modeling strategy in edgeR to address the over-dispersion observed in gene
expression count data (Landau and Liu, 2013), which performs well relative to other strategies
(Rapaport et al., 2013, Soneson and Delorenzi, 2013). Our workflow for this project was based
on best practices previously described in detail elsewhere (Anders et al., 2013, Love et al.,
2015). General linear models were used to estimate overall, gene-wise, and tag-wise
dispersion, using the Cox-Reid-adjusted likelihood method (Cox and Reid, 1987, McCarthy et
al., 2012). Negative-binomial generalized linear models (GLMs) were fit for each gene
examining differences by high and low minority stress groups, and accounting for urine
toxicology positive or negative for stimulants. Gene identifiers were annotated with Entrez
gene IDs and names were annotated using the HUGO Gene Nomenclature Committee
database (“HGNC database of human gene names | HUGO Gene Nomenclature Committee,”
n.d.). Surrogate variable analysis was used to capture unspecified heterogeneity (Leek et al.,

2012), and surrogate variables were retained unless highly correlated with the sexual minority
stress phenotype (p < .10). Likelihood ratio tests were used to test differences between the
high and low minority stress groups. The Benjamini-Hochberg procedure was used to estimate
the false discovery rate (FDR) with an FDR cut-off of 0.10.
Gene set or pathway analyses, examining differences in perturbations among groups of genes
were completed using Generally Applicable Gene-set Enrichment (GAGE, Luo et al., 2009b),
using a competitive method to identify if a given pathway of interest is differentially expressed
more often between high and low minority stress groups when compared to a complementary
set of genes (Emmert-Streib and Glazko, 2011, Goeman and Bühlmann, 2007) using an FDR
cutoff of 0.10. Additional gene set analyses were conducted using signaling pathway impact
analysis (SPIA, Tarca et al., 2009) to identify purturbations in a biological pathway considering
both the level of differential expression of individual genes as well as the topology of the
pathway. The Kyoto Encyclopedia of Genes and Genomes (Kanehisa et al., 2011, KEGG:
Kyoto Encyclopedia of Genes and Genomes, n.d.) database was used to define gene sets.
Once results were obtained, existing research on each of the differentially expressed genes
was reviewed for relevance to the hypothesized mechanisms of inflammation, immune
function, cancer, or cardiovascular function. Pathways were categorized for potential
relationships to each of these hypothesized mechanisms.

3. Results
3.1. Participants
Thirty-eight of 62 participants met all eligibility criteria and had RNA sequencing data available
for analysis. The current study utilized data from the 39 participants who completed minority
stress measures; the 23 participants lacking minority stress measures were enrolled prior to
the integration of these measures into the study protocol. There were no differences in
demographic or clinical characteristics among those who underwent RNA sequencing who
received or did not receive minority stress measures, with the exception that participants who
received minority stress measures were more likely to have a higher CD4+ T-cell count
(M = 730) than those who did not (M = 474, p < .001). One additional sample was removed from
the 39 who had sequencing data because the participant’s viral load was greater that 200
copies per mL, thus they did not meet our inclusion criteria, for a total of 38 participants within
this study. Of the 38 participants, 20 were designated low sexual minority stress and 18 were
designated high sexual minority stress. There were no differences between low versus high
minority stress groups on age, time since HIV diagnosis, CD4+ T-cell count, number of days
within the past 30 that methamphetamine was used, drug or alcohol use severity, depression,
PTSD symptoms, sexual orientation, race/ethnicity, proportion with undetectable viral load,
proportion on different ART regimens, or proportion with a positive urine toxicology screen for
stimulants. There were no differences in plasma levels of TNF-α and IL-6 in the low versus
high minority stress groups. Participant demographic information and p-values of chi-square
analyses and t-tests of demographic and clinical variables by low and high minority stress
groups are found in Table 1.

Table 1. Demographic information and clinical characteristics of 38 sexual minority men living
with HIV by low and high minority stress.
Low sexual minority
stress (n = 20)
M (SD)
Age
41.6 (8.2)
Time since HIV diagnosis
13.8 (8.4)
CD4+ T-cell count (cells/mm3) 708.3 (273.6)
Methamphetamine use days
5.0 (6.5)
(past 30 days)
ASI drug score
0.1 (0.1)
ASI alcohol score
0.1 (0.1)
CES-D depression
22.6 (13.7)
PCL-C PTSD
48.4 (15.0)
Log10 interleukin-6 (IL-6)
0.3 (0.3)
Log10 tumor necrosis factor –
1.7 (0.2)
alpha (TNF-α)
n (%)
Sexual orientation
Gay
17 (85.0%)
Bisexual
2 (10.0%)
Heterosexual
1 (5.0%)
Race/ethnicity
Asian
0 (0.0%)
African American/Black
2 (10.0%)
Hispanic/Latino
3 (15.0%)
Multiracial
2 (10.0%)
White
13 (65.0%)
ART Regimen
INSTI & NRTI
3 (15.8%)
Boosted PI & NRTI
6 (31.6%)
NNRTI & NRTI
5 (26.3%)
Other HAART
4 (21.0%)
No HAART
1 (5.3%)
Undetectable HIV viral load
16 (80.0%)
(<40 copies/mL)

High sexual minority
stress (n = 18)
M (SD)
46.0 (5.3)
12.9 (8.2)
780.4 (280.3)

Difference,
p
0.06
0.73
0.43

8.1 (8.8)

0.22

0.2 (0.1)
0.2 (0.1)
28.7 (11.8)
52.2 (13.0)
0.4 (0.3)

0.10
0.48
0.15
0.41
0.29

1.7 (0.2)

0.96

n (%)
0.40
14 (77.8%)
4 (22.2%)
0 (0.0%)
0.32
1 (5.6%)
2 (11.1%)
6 (33.3%)
3 (16.7%)
6 (33.3%)
0.06
8 (50.0%)
2 (12.5%)
6 (37.5%)
0 (0.0%)
0 (0.0%)
14 (77.8%)

0.87

Low sexual minority High sexual minority Difference,
stress (n = 20)
stress (n = 18)
p
Urine positive for stimulants 8 (40.0%)
12 (66.7%)
0.10
Abbreviations: ART = antiretroviral therapy; ASI = Addiction Severity Index; CES-D = Center for the
Epidemiologic Study -Depression Scale; HAART = highly active anti-retroviral therapy; INSTI = integrase strand
transfer inhibitor; M = mean; NNRTI = non-nucleoside reverse transcriptase inhibitor; NRTI = nucleoside reverse
transcriptase inhibitor; PCL-C = PTSD Checklist – Civilian Version; PI = protease inhibitor; PTSD = post traumatic
stress disorder; SD = standard deviation.

3.2. Gene expression results
Mean RNA integrity numbers were 7.2 (range 6.3–9.1). High replicability was supported with
clustering of technical replicates in MDS plots and with mean within-replicate Pearson
correlations coefficients of 0.999 between technical replicates across different lanes. After
filtering out genes that were lowly expressed within the sample (<1 count per million in 10 of
the samples), 19,541 genes remained for consideration. Mean library size was 14,020,862
after filtering. Eight surrogate variables were found, 7 were used in modeling, with the
remaining 1 removed from models due to high correlation with sexual minority stress
groupings.
3.3. Differential gene expression
In total, 90 genes were differentially expressed at an FDR of 0.10. Of these 90 genes, 69 were
upregulated and 21 were downregulated. Genes differentially expressed at an FDR of 0.10
with suspected relevance to inflammation or the biological functions that were shown to be
previously related to sexual minority stress (i.e., immune function, cancer, or cardiovascular
function; 41 genes in total), are listed in Table 2. The complete list of genes is available within
Supplementary Materials (S2).
Table 2. Selected differentially expressed genes (FDR < 0.10) between low and high sexual
minority stress groups (N = 38 sexual minority men living with HIV) grouped by potential
biological relevance to inflammation, immune function, cancer, or cardiovascular function, and
including citations that suggested this biological relevance.
Function

Genea

Log fold
difference

FDR adjusted
p value

Inflammation
BTLA (Bekiaris et al., 2013, Otsuki et al., 2006) 0.582
PLCB2 (Mao et al., 2016)
−0.357

0.062
0.076

GZMA (Müllbacher et al., 1999)
0.828
CD69 (Sancho et al., 2005)
0.798
CLEC4E (Behler-Janbeck et al., 2016, Kottom
−0.576
et al., 2017)

0.050
0.072

Immune

0.083

Function

Genea
KLRB1 (Llibre et al., 2016)
PPP1R12C (Dutheil et al., 2014)

Log fold
difference
0.569
−0.384

FDR adjusted
p value
0.098
0.088

0.480

0.006

1.011
−1.056

0.050
0.050

1.230

0.050

1.305

0.050

0.676

0.053

0.476

0.053

0.763
−0.584

0.053
0.057

0.602

0.062

1.028
0.578

0.062
0.064

−0.493

0.076

0.761
0.897

0.076
0.076

0.694

0.076

0.498

0.076

0.450

0.076

0.727
−0.939

0.076
0.076

0.435

0.077

0.500
0.589

0.083
0.083

Cancer
ZNF426 (Yang et al., 2009, Yang and Wood,
2007)
RPS15A (Chen et al., 2016, Yao et al., 2016)
CACNA1E (Natrajan et al., 2006)
TRIM2 (Chen et al., 2015, Panaccione et al.,
2017)
RPL9 (Baik et al., 2016)
ERH (Schmitt et al., 1999, Weng and Luo,
2013)
SKIL (Annala et al., 2015, Hagerstrand et al.,
2013, Shinozuka et al., 2013, Zhu et al., 2016)
RPS21 (Arthurs et al., 2017)
PRR14 (Yang et al., 2016)
BIRC3 (Wang et al., 2016, Wang et al., 2017,
Yamato et al., 2015)
RPS7 (Zhang et al., 2016)
RPL35A (Oliver et al., 2017)
JDP2 (Chen et al., 2017, Yuanhong et al.,
2010)
SNRPF (Sun et al., 2016)
RPL23 (Wu et al., 2012)
EIF5A2 (Li et al., 2014a, Luo et al., 2009a,
Meng et al., 2015)
ANKRD46 (Cheng et al., 2012)
ANXA2R (D’Souza et al., 2012, Shiozawa et
al., 2008)
CA1 (Zheng et al., 2015)
SP2 (Phan et al., 2004, Zhao et al., 2014)
PSMD10 (Fu et al., 2002, Meng et al., 2010,
Qin et al., 2016)
MAPKAPK5-AS1 (Zhang et al., 2015)
RPS14 (Ebert et al., 2008, Wang et al., 2014)

Genea

Function

EIF3E (Grzmil et al., 2010, Li et al., 2014a, Li
et al., 2014b)
RPL31 (Maruyama et al., 2014)
UGCG (Liu et al., 2011a, Liu et al., 2011b)
ZDHHC2 (Peng et al., 2014, Yan et al., 2013)
USP45 (Perez-Oliva et al., 2015)
NUDCD1(Jin et al., 2008, Rao et al., 2014)
RPS20 (De Bortoli et al., 2006, Yong et al.,
2015)
PHF14 (Zhang et al., 2017)
FANCM (Alix-Panabières et al., 2017, Matta et
al., 2013)

Log fold
difference

FDR adjusted
p value

0.474

0.083

1.077
0.345
0.420
0.393
0.643

0.083
0.083
0.083
0.083
0.087

0.545

0.089

0.367

0.089

0.449

0.089

0.599
0.677

0.077
0.083

Cardiovascular
AKAP7 (O’Connell et al., 2017)
ZNF260 (Komati et al., 2011)

aGene name is accompanied by references relating it to this biological process or function. References were
included irrespective of tissue or direction of relationship with biological process or function.

3.4. Pathway analysis
In GAGE analysis, there were 138 two-directional perturbed gene sets. A comprehensive list of
two-directional perturbed pathways is included as a Supplementary Material (S3). Selected 2
directional pathways that are related to inflammation or previously observed relationships
between sexual minority stress and biological function (i.e., immune function, cancer,
cardiovascular) are listed in Table 3. Of note, as can be seen in Supplementary Materials,
metabolic pathways from the KEGG database emerged frequently in two directional
perturbation gene set analyses. SPIA analysis found one significant pathway: the neuroactive
ligand-receptor interaction (KEGG ID: 04080), which was activated in the high sexual minority
stress group (pGFDR = 0.008). The significance of this pathway was driven by perturbation
(ppert = 0.000005), and not an enrichment of the number of differentially expressed genes
(pNDE = 0.97). This pathway was also detected in 2 dimensional perturbation analyses using
GAGE (q = 0.0000007).

Table 3. Selected gene sets identified in GAGE analysis to have 2 dimensional perturbation
below an FDR < 0.10 between low and high sexual minority stress groups in 38 sexual minority
men living with HIV with potential relevance to inflammation or observed health disparities
among sexual minority people or biological outcomes previously related to minority stress
(e.g., cardiovascular risk, inflammation, HIV progression, cancer, or infection/immune).
Function Database and ID
Name
q value
Inflammation
KEGG 04060
Cytokine-cytokine receptor interaction 9.87−07
KEGG 04062
Chemokine signaling pathway
2.36−05
KEGG 05322
Systemic lupus erythematosus
0.0008
KEGG 04610
Complement and coagulation cascades 0.001
KEGG 04514
Cell adhesion molecules
0.004
KEGG 04620
Toll-like receptor signaling pathway
0.006
KEGG 04940
Type I diabetes mellitus
0.006
KEGG 05310
Asthma
0.010
KEGG 05332
Graft-versus-host disease
0.010
KEGG 05145
Toxoplasmosis
0.013
KEGG 04145
Phagosome
0.019
KEGG 04664
Fc epsilon RI signaling pathway
0.021
KEGG 04670
Leukocyte transenothelial migration
0.025
Immune
KEGG 04650
Natural killer cell mediated cytotoxicity 5.57−05
KEGG 05150
Staphylococcus aureus infection
0.003
KEGG 04660
T cell receptor signaling pathway
0.015
Cancer
KEGG 04080
Neuroactive ligand-receptor interaction 6.58−07
KEGG 05200
Pathways in cancer
1.50−05
KEGG 05211
Renal cell carcinoma
0.005
KEGG 05219
Bladder cancer
0.013
KEGG 05221
Acute myeloid leukemia
0.016
KEGG 05222
Small cell lung cancer
0.016
KEGG 05223
Non-small cell lung cancer
0.017
KEGG 05212
Pancreatic cancer
0.037
Cardiovascular
KEGG 04260
Cardiac muscle contraction
0.0003
KEGG 04270
Vascular smooth muscle contraction
0.005

Function Database and ID
Name
KEGG 04614
Renin-angiotensin system
KEGG 05414
Dilated cardiomyopathy

q value
0.013
0.013

4. Discussion
This study found that sexual minority stress is related to differential expression of individual
genes and pathways in leukocytes that are implicated in inflammation, immune function,
cancer, and cardiovascular function. In total, 90 single genes were differentially expressed at
an FDR of <0.10, of which 41 are related to hypothesized mechanisms underlying minority
stress: inflammation, immune function, cancer, and cardiovascular function. Notably, these
relationships between minority stress and differential gene expression were observed after
controlling for recent stimulant use. Furthermore, 138 pathways evidenced 2-directional
perturbation, 35 of which are related to hypothesized mechanisms. The neuroactive ligand
receptor interaction pathway was identified through both enrichment pathway analysis and
perturbation analysis, driven by multiple genes evidencing perturbation on this pathway. These
results add to the emerging body of research that has identified relationships between minority
stress and biological functioning (e.g., Cole et al., 1996a, Cole et al., 1996b, Frost et al., 2015,
Huebner and Davis, 2005) and suggest that continued investigation of these relationships is
warranted. In this study, the approach employed to assess differential gene expression and
pathway analysis builds on prior studies, which examined the relationship between sexual
minority stress and HIV progression and mortality, cancer or infection, and cortisol. This study
provides a first step in exploring the biological processes whereby sexual minority stress may
influence the health of sexual minority people.
Relevant to the health and immune function of individuals living with HIV, this study found that
7 genes and 16 pathways related to inflammation or immune functioning were differentially
expressed between low and high minority stress groups. For example, the differentially
expressed genes include BTLA, whose proteins are associated with homeostasis of
inflammatory responses within cells (Bekiaris et al., 2013), KLRB1, which inhibits natural killer
cell cytotoxicity, and CD69, which has a role in the regulation of immune function and
inflammation (Sancho et al., 2005). Interestingly, although we found differential perturbation in
the cytokine-cytokine receptor interaction pathway (KEGG 04060) of which TNF and IL-6 are
members, and that TNF-α and IL-6 are common inflammatory markers, we did not see a
difference between groups in the levels of either in plasma or in gene expression. The
relationship between circulating cytokines and gene expression is not always consistent, as
some studies have observed differences in circulating cytokines when no difference was
observed in gene expression (Moldoveanu et al., 2000), while other studies have, similar to the
study reported here, found evidence for differences in gene expression related to inflammation
when no differences were observed in circulating cytokines such as IL-6 (Creswell et al., 2012,
Miller et al., 2009, Murphy et al., 2012).. Moreover, de novo gene expression is but one of
several means of regulation (e.g., sequestration of proteins in complexes such as
inflammaosomes) and thus differences in gene expression may not immediately result in
differences in protein levels and vice versa. Finally, given that circulating cytokines can be
impacted by multiple factors (e.g., co-occurring mental illness, Hoge et al., 2009, Schiepers et

al., 2005, or viral infection, Yu et al., 2011), a larger sample size may be required to detect
differences in circulating cytokines in relation to minority stress. This supports the hypothesis
that although immune function and inflammation are associated with minority stress, a broader
set of biomarkers should be investigated in future studies. While these results corroborate
previous research that has found a relationship between minority stress and HIV related
outcomes such as faster progression to AIDS, AIDS mortality, and lower CD4 T-cell count
(Cole et al., 1997, Norcini Pala et al., 2015), more research is needed to elucidate the specific
mechanisms by which minority stress may be related to poorer HIV outcomes. Our results
suggest that dysregulation of the immune and inflammatory systems could be a potential area
for further investigation.
This study found that between low and high sexual minority stress groups, 32 differentially
expressed genes and 8 perturbed pathways were related to cancer. These results corroborate
work which previously found a relationship between minority stress and development of cancer
(Cole et al., 1996a). To appropriately contextualize these results, it is important to note that we
included genes related to cancer irrespective of their tissue of origin or the directionality of this
relationship. Furthermore these results may in part be biased by the amount of cancer
research that is reflected in the literature; while many genes are being documented as related
to cancer development (e.g., cell survival and proliferation, biological functions which exist
outside of cancer), their roles are likely more complex than solely based on their contribution to
cancer pathogenesis. In time our understanding of the complex networks of cancer
development will have greater specificity. In the meantime, we observed differential expression
of genes related to cancer development of viral origins, such as ZNF426 (Yang et al., 2009,
Yang and Wood, 2007), which is important to the replication of Kaposi’s sarcoma associated
herpes virus, and those that have been shown to be related to cancer development (e.g., SKIL,
Annala et al., 2015, Hagerstrand et al., 2013, Shinozuka et al., 2013, Zhu et al., 2016) or
aggressiveness (e.g. EIF5A2, Li et al., 2014a, Li et al., 2014b, Luo et al., 2009a, Luo et al.,
2009b, Meng et al., 2015). Notably, the relationship observed in this study between minority
stress and differential expression of ZNF426 support prior research that illustrated the role of
autonomic nervous system activity in the reactivation of Kaposi’s sarcoma associated herpes
virus (Chang et al., 2005). The neuroactive-ligand receptor interaction (KEGG ID: 04080) also
appears to be associated with cancer (e.g., Fang et al., 2013, Liu et al., 2015, Wei et al., 2015,
Wei et al., 2012), though this pathway has also been associated with other phenomena (e.g.,
chronic fatigue syndrome as in Fang et al., 2006, or viral infection as in Huang et al., 2008). Of
note, the measure of minority stress that we used within this study likely detects persistent
minority stress, as opposed to acute minority stress (e.g., exposure to a single instance of
discrimination), and it is likewise expected that greater cancer risk would be conferred over
time rather than through acute exposure. More research is needed to understand the specific
cascade of biological events that may result after acute exposure to sexual minority stressors,
through prolonged exposure to minority stressors, and to understand if those responses can
be modified through interventions.
The genes and pathways documented here in relationship to minority stress warrant replication
in order to further refine which genes would be most useful as outcomes in future studies
examining minority stress or interventions to reduce the impacts of this unique, pernicious form
of stress. Future research is needed to validate the candidate genes identified in this study in

an independent sample of participants. The genes and pathways identified here and in
replication studies could function as outcomes within studies examining the efficacy of
cognitive or behavioral interventions intended to reduce the deleterious impacts of minority
stress. These genes or pathways may even be considered as measures that could enable
titration or adjustment of these interventions (e.g., changes in the expression of these genes
would indicate efficacy, while lack of change would warrant adjustment of the intervention).
While unable to examine it here, the complex paths by which sexual minority stress and its
relationship with gene expression may interact with psychological processes such as
rumination, hopelessness, or self-schemas (i.e., expansion of work by Hatzenbuehler, 2009) is
an important area of future research. Within this model, it is anticipated that gene expression,
as an active biological process responsible for the biological behavior of the organism, may
both be impacted by and reciprocally impact these psychological processes. In addition to
psychological processes, behavioral processes associated with sexual minority stress (e.g.,
smoking or substance use, Livingston et al., 2017) are important to consider. Additionally,
social processes which may impact biological functioning (e.g., childhood adversity, Miller and
Cole, 2012, or social isolation, Cole et al., 2007) and may have reciprocal relationships with
minority stress (e.g., the higher rates of childhood victimization reported among sexual minority
people, Friedman et al., 2011) will also be important to consider within this model. Identifying
ways in which the response to sexual minority stressors may impact subsequent biological
functioning will be an important area for future research. Sexual minority stress was
considered here while controlling for recent stimulant use. As sexual minority stress is
predictive of substance use (Hatzenbuehler et al., 2008, Livingston et al., 2017), additional
studies with larger samples are needed to examine whether or not there is a mediating or
moderating effect for substance use in the relationship between sexual minority stress and
expression of genes on these pathways. Of note, none of the differentially expressed genes
reported here overlapped with those found to be related to stimulant use in a companion paper
resulting from this project, which suggests that the relationship between sexual minority stress
and gene expression may be unique and not a direct result of stimulant use. Future research is
also needed to examine if these same candidate genes or pathways are responsive to stress
in general, and sexual minority stress in particular, and whether or not these patterns of gene
expression may be modified through intervention, either through modification of health
behaviors or by targeting the stress directly.
There are limitations to consider in contextualizing these results and considering future
directions for research. First, this study was within individuals who had used
methamphetamine recently, though not all participants had used methamphetamine or other
stimulants in the days preceding the study visit. Stimulant use that had occurred in the days
just prior to the study visit was biologically confirmed via urinalysis within this sample, and we
controlled for this variable within analysis to control for the effects of stimulants. This study was
also conducted among sexual minority men living with HIV, and the effects among people
living with HIV may be more robust than effects among persons who are living without a cooccurring disease process. Much of the literature to date that has documented a relationship
between minority stress and biological functioning appears to be among individuals with HIV,
and it remains unknown if that is because people living with HIV are generally more studied, or

if it is because the same relationships have not been observed among individuals who do not
have HIV.
This study did not account for important medical comorbidities that could be occurring among
people living with HIV, though the lack of observed differences in CD4 T cell count and IL-6
levels suggests relatively comparable health status of the high and low minority stress groups.
Comorbidities can be particularly deleterious for health among those living with HIV and are
linked to greater risk of morbidity (Lohse et al., 2011, Rodriguez-Penney et al., 2013). These
comorbidities should be accounted for in subsequent research. Given the modest size of the
sample, it is likely that additional differences in gene expression and circulating cytokines were
not identified (i.e., false negatives). This study consisted only of men who were assigned birth
sex of male; future work should examine the relationship between minority stress and
expression of genes among sexual minority women and gender minority people. For example,
sexual minority women are at greater risk for being overweight or obese (Boehmer et al., 2007)
suggesting that biological pathways between stress related to sexual minority status and
health may be different (e.g., metabolic) among this population. This study also focused solely
on minority stress, while future work should explore the complex relationships between
minority stress and other psychosocial factors that may be related to both gene expression and
minority stress such as childhood adversity and social isolation. This study included sexual
minority men irrespective of their sexual identity. Sexual minority stressors may be uniquely
experienced by sexual minority men who identify as heterosexual (as one did in this study).
In conclusion, our study is among the first to observe a relationship between sexual minority
stress and differential expression of single genes as well as sets of genes that are functionally
related to inflammation, immune function, cancer, and cardiovascular function. Our results
suggest several potential biological pathways for future work investigating the relationship
between sexual minority stress and health.
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